APA (7th ed.) Citation

Daveluy, S., Gottlieb, A. B., Augustin, M., Lev-Tov, H., Szepietowski, J. C., Horváth, B., . . . Thorlacius, L. (2026). Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II. Dermatology & Therapy, 16(7), 3315. https://doi.org/10.1007/s13555-026-01790-2

Chicago Style (17th ed.) Citation

Daveluy, Steven, et al. "Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II." Dermatology & Therapy 16, no. 7 (2026): 3315. https://doi.org/10.1007/s13555-026-01790-2.

MLA (9th ed.) Citation

Daveluy, Steven, et al. "Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II." Dermatology & Therapy, vol. 16, no. 7, 2026, p. 3315, https://doi.org/10.1007/s13555-026-01790-2.